Related Experiment Video

Updated: May 11, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Pharmacotherapy of metastatic melanoma: emerging trends and opportunities for a cure

Francesca Pretto1, Dario Neri

  • 1Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Wolfgang-Pauli-Strasse 10, CH-8093 Zurich, Switzerland.

Pharmacology & Therapeutics
|May 29, 2013
PubMed

Insights

Metastatic melanoma treatments like Vemurafenib and Ipilimumab show promise but face resistance and toxicity. Future research must focus on developing more effective therapies for advanced melanoma patients.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Research

Background:

  • Metastatic melanoma is a highly lethal cancer with limited response to traditional chemotherapy (Dacarbazine, Paclitaxel).
  • Emerging therapies (Vemurafenib, Ipilimumab) offer new options for advanced melanoma but are associated with resistance and significant toxicities.

Purpose of the Study:

  • To review current approved and experimental therapies for metastatic melanoma.
  • To discuss the mechanisms of action and efficacy of these treatments.
  • To identify future directions for pharmaceutical research in melanoma treatment.

Main Methods:

  • Literature review of approved and experimental therapies for metastatic melanoma.
  • Analysis of drug mechanisms of action.
  • Evaluation of reported clinical efficacy data.

Main Results:

  • Small molecule drugs and biologics have expanded therapeutic choices for metastatic melanoma.
  • Challenges include acquired resistance and high-grade toxicities associated with current advanced treatments.
  • Efficacy data varies across different therapeutic agents.

Conclusions:

  • There is a critical need for novel and more effective treatments for metastatic melanoma.
  • Further research into small molecule drugs and biologics is essential.
  • Understanding resistance mechanisms and toxicity profiles will guide future drug development.
Keywords:
CTLA-4DTICEDBERKGM-CSFIFN-αIL-2IL2ImmunocytokinesInterferon-αInterleukin-2IpilimumabMAPKMTDMelanomaPD-1RPD-L1 and 2PI3KVemurafenibcytotoxic T-lymphocyte antigen 4dacarbazineextra-domain B of fibronectinextracellular-signal-regulated kinasesgranulocyte-macrophage colony-stimulating factormaximum tolerated dosemitogen-activated protein kinasesphosphatidylinositol 3-kinasesprogrammed cell death 1 ligand 1 and 2programmed death-1 receptor

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models05:33

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Published on: September 6, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...